LORQESS

DEAD

Serial Number

86677907

Owner

Arena Pharmaceuticals GmbH

Attorney

Allison Strickland Ricketts

Filing Date

Jun 29, 2015

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

LORQESS Trademark

Serial Number: 86677907 • Registration: 4901254

LORQESS is a trademark filed by Arena Pharmaceuticals GmbH on June 29, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Arena Pharmaceuticals GmbH (74 trademarks)

Untere Bruhlstrasse 4
CH-4800 Zofingen , CH

Entity Type: 99

Legal Representation

Attorney of Record

Allison Strickland Ricketts

3,322 trademarks filed View all →

Correspondence Address

ALLISON STRICKLAND RICKETTS Fross Zelnick Lehrman & Zissu P C

4 TIMES SQUARE

17TH FLOOR

New York

NY 10036

Trademark Details

Filing Date

June 29, 2015

Registration Date

February 16, 2016

Published for Opposition

December 1, 2015

Cancellation Date

August 26, 2022

Filing History

CANCELLED SEC. 8 (6-YR)

Aug 26, 2022 C8..

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Feb 16, 2021 REM1

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

Apr 5, 2017 CORV

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 31, 2017 CRFA

REGISTERED-PRINCIPAL REGISTER

Feb 16, 2016 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 1, 2015 NPUB

PUBLISHED FOR OPPOSITION

Dec 1, 2015 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 11, 2015 NONP

ELECTRONIC RECORD REVIEW COMPLETE

Oct 23, 2015 FIXD

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Oct 16, 2015 ERRR

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 13, 2015 CNSA

ASSIGNED TO EXAMINER

Oct 6, 2015 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 6, 2015 NWOS

NEW APPLICATION ENTERED

Jul 2, 2015 NWAP

Related Trademarks

More from this Owner

BELVIQ XR

More in Same Class

B-NERGETICS BE THE ULTIMATE YOU

SEPPIC